Fiscal 2015:

Another record year for Bayer

Focus on the Life Sciences following the successful stock market flotation of Covestro / Substantial sales and earnings increases at HealthCare / Good business development at CropScience despite a weaker market environment / Covestro posts strong earnings improvement / Group sales increase to EUR 46,324 million (plus 12.1 percent / Fx & portfolio adj. plus 2.7 percent) / EBITDA before special items advances by 18.2 percent to EUR 10,266 million / EBIT improves by 15.8 percent to EUR 6,250 million / Net income increases 20.0 percent to EUR 4,110 million / Core earnings per share up 16.0 percent to EUR 6.83 / Forecast for 2016: further growth in sales and earnings more